Resource Center
Resource Center
In a small village in rural east-central Uganda, baby Josephin is happily babbling to her mother Kevina and crawling around the yard. She has recovered well from a bout of bad diarrhea that she was suffering from just one day ago. Josephin is one of the lucky ones. She was able to access effective treatment...
Read more
CHAI supports national governments to expand high-quality care and treatment to people living with HIV/AIDS. CHAI negotiates reduced prices for antiretrovirals (ARVs) on behalf of members of its procurement consortium. See the 2016 CHAI ARV Reference Price List here.
Read more
Pneumonia is the leading cause of death for children globally, taking more lives annually than HIV, tuberculosis, and malaria combined. It is estimated that a child dies from pneumonia every 35 seconds. Pneumonia, a severe respiratory infection in which a child’s lungs fill with fluid, makes it difficult for them to absorb and exchange oxygen....
Read more
A Neglected Disease in Africa Sub-Saharan Africa’s cancer burden is significant and growing. In 2012, there were an estimated 626,400 new cases of cancer and 447,700 deaths from cancer in Sub-Saharan Africa. The World Health Organization projects that by 2030, close to 1 million people will die of cancer each year in Sub-Saharan Africa....
Read more
Sixteen years ago, the 13th International AIDS Conference (IAS) convened in Durban, South Africa, to “break the silence” on the millions of preventable AIDS-related deaths occurring around the world. The summit was notable as it laid out the clear case that HIV causes AIDS, allowed people living with HIV/AIDS (PLWHA)’s voices to be heard, and...
Read moreCHAI’s ARV Market Report provides a global perspective on the ARV marketplace in low- and middle-income countries in 2015 and outlines CHAI’s expectations on how the market will evolve over the next five years. See the ARV Market Report here.
Read more
In Malawi, innovative models have been developed to optimize the efficiency of HIV service delivery in order to scale up access to treatment. In particular, three key models of differentiated care have emerged: multi-month prescriptions; fast-track drug refills; and community ART groups. In collaboration with the Ministry of Health of Malawi, CHAI conducted a mixed...
Read more
Aurobindo Pharma Limited is pleased to announce the tentative approval of Dolutegravir 50mg from US Food & Drug Administration (USFDA) for the treatment of HIV. This important milestone marks the first FDA approval of a generic version of Dolutegravir (DTG), an integrase strand transfer inhibitor recommended for use in treatment-naïve patients by the US...
Read more
The Clinton Health Access Initiative, Inc. (“CHAI”) was founded in 2002 as a Clinton Foundation Initiative. Today, the CHAI Board of Directors, which is fully committed to and proud of CHAI’s life-saving work, announced the following changes will be implemented if Secretary Clinton is elected President of the United States: The five members of CHAI’s Board...
Read more
In 2019, updates to historical datasets were made upon consultation with relevant current suppliers, including the addition of a new supplier’s data. Please find the most up-to-date report here. The 2016 Family Planning Market Report can be found below.
Read more